My favorite JE candidate is SOMX. http://www.themarketfinancial.com/uncovering-the-billion-dollar-potential-in-vivus-hgsi-dndn-somx-ntri-med-vvus-orex-arna/111040 Eventually they will be selling Silenor over the counter with their partner Proctor & Gamble Unlike most other sleep products, Silenor is not scheduled. The financing and dilution are done for now. Technically, there is a gap that will get filled at 3.25. That is a VERY conservative target for the January Effect